03.04.2012 • News

Lonza Appoints Richard Ridinger as New CEO

At a meeting on 2 April 2012, the Board of Directors of Lonza elected Richard Ridinger as the new CEO of Lonza. Mr. Ridinger, 53, will become CEO of Lonza effective 1 May. Rolf Soiron was acting CEO ad interim, since the end of January.

Richard Ridinger has held numerous leadership functions at Henkel for 14 years and Cognis for 11 years. Most recently, Mr. Ridinger was responsible for Care Chemicals, the largest sector at Cognis with approximately 3,000 employees. During his tenure, sales increased by 60% to €1.75 billion over six years, as he successfully repositioned the business in the market.

At the 2 April meeting, the Board of Directors also appointed Marc Funk, Group General Counsel and Board Secretary, to become a member of the Management Committee. Marc Funk joined Lonza in January 2009; prior he was associate general counsel at Merck Serono.

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.